MBCI — MabCure Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $0.13m
- $0.50m
Annual income statement for MabCure, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 December 31st | 2008 December 31st | R2009 December 31st | C2010 December 31st | 2011 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.106 | 0.536 | 1.37 | 1.02 | 12.6 |
| Operating Profit | -0.106 | -0.536 | -1.37 | -1.02 | -12.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.012 | -0.023 | -0.02 | -0.014 |
| Dividends per Share |